Which Comes First: The Woman or Her Eggs?
By Ruha Benjamin,
Huffington Post
| 04. 17. 2013
[Quotes CGS's Marcy Darnovsky]
To Pay or Not to PayImagine two women sitting in a waiting room -- one is a store clerk, and the other is an investment banker -- preparing to donate their eggs for a particular type of stem cell research.* There are some who think that payment could coerce women, especially those who are low-income, to undergo the
invasive procedure.** Marcy Darnovsky, the executive director of the Center for Genetics and Society,
says that restricting payment can help prevent "the emergence of a market in which predominantly poor women are the ones who wind up selling their eggs."
Others insist that women are perfectly capable of weighing their options, and that egg donors should be financially rewarded for their time and trouble. UC Hastings law professor
Radhika Rao contends:
[E]veryone else involved in the production of human embryonic stem cells is entitled to compensation. The researchers who invest intellectual capital and the companies and universities that invest financial capital will surely share in any profits ... so why not those who provide the human capital in the form...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...